COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02291887
Recruitment Status : Completed
First Posted : November 17, 2014
Last Update Posted : November 17, 2017
Genentech, Inc.
Information provided by (Responsible Party):
Associated Retinal Consultants, Michigan

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 1, 2015
Actual Study Completion Date : July 1, 2015